ResMed Inc. (RMD) Earnings Call Analysis

NYSE · Healthcare · Medical Instruments & Supplies

24/25

Growth 5 Margin 4 Expansion 5 Platform 5 Financial 5

latest quarter score

Earnings Reports

24
ResMed (RMD) Q4 2026: $1.85B Capital Return Signals Portfolio Sharpening and Margin Discipline
August 07, 2026
25
ResMed (RMD) Q3 2026: Gross Margin Expands 290bps as Fabric Mask Adoption and Noctrix Deal Reshape Sleep Health Portfolio
May 01, 2026
25
ResMed (RMD) Q2 2026: Gross Margin Expands 310 bps, Underpinning Strategic Flexibility
January 30, 2026
25
ResMed (RMD) Q1 2026: Gross Margin Expands 280bps as Portfolio Shift Targets High-Margin SaaS
October 31, 2025
25
ResMed (RMD) Q4 2025: Gross Margin Expands 230bps as Digital Sleep Ecosystem Drives Operating Leverage
July 31, 2025
25
ResMed (RMD) Q3 2025: Gross Margin Rises 140bps as Tariff Exemption Secures U.S. Profitability
July 04, 2025
ResMed (RMD) Q2 2025: Devices Up 12% in Americas, Capturing Early Demand from Wearables and GLP-1 Tailwinds
January 30, 2025

Browse all companies